BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shang QX, Yang YS, Gu YM, Zeng XX, Zhang HL, Hu WP, Wang WP, Chen LQ, Yuan Y. Timing of surgery after neoadjuvant chemoradiotherapy affects oncologic outcomes in patients with esophageal cancer. World J Gastrointest Oncol 2020; 12(6): 687-698 [PMID: 32699583 DOI: 10.4251/wjgo.v12.i6.687]
URL: https://www.wjgnet.com/1948-5204/full/v12/i6/687.htm
Number Citing Articles
1
Mithun Nariampalli Karthyarth, Anvin Mathew, Deepti Ramachandra, Anuj Goyal, Neeraj Kumar Yadav, Kamireddy Madana Raghava Reddy, Nirjhar Raj Rakesh, Gourav Kaushal, Puneet Dhar. Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysisEsophagus 2023; 20(3): 390 doi: 10.1007/s10388-023-00989-y
2
Chanyoot Bandidwattanawong. Multi-disciplinary management of esophageal carcinoma: Current practices and future directionsCritical Reviews in Oncology/Hematology 2024; 197: 104315 doi: 10.1016/j.critrevonc.2024.104315
3
Theresa A. Gelzinis. The Society of Thoracic Surgeons/American Society for Radiation Oncology/American Society of Clinical Oncology Recommendations on the Care of Patients With Localized Esophageal CancersJournal of Cardiothoracic and Vascular Anesthesia 2024; 38(7): 1445 doi: 10.1053/j.jvca.2024.03.023
4
Wei-Xiang Qi, Shuyan Li, Jifeng Xiao, Huan Li, Jiayi Chen, Shengguang Zhao. A machine learning approach using 18F-FDG PET and enhanced CT scan-based radiomics combined with clinical model to predict pathological complete response in ESCC patients after neoadjuvant chemoradiotherapy and anti-PD-1 inhibitorsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1351750
5
Jiacong Liu, Linhai Zhu, Xuhua Huang, Zhongjie Lu, Yanye Wang, Yuhong Yang, Jiayue Ye, Chen Gu, Wang Lv, Chong Zhang, Jian Hu. Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05696-4
6
Stephanie G. Worrell, Karyn A. Goodman, Nasser K. Altorki, Jonathan B. Ashman, Traves D. Crabtree, Jennifer Dorth, Scott Firestone, David H. Harpole, Wayne L. Hofstetter, Theodore S. Hong, Kalie Kissoon, Geoffrey Y. Ku, Daniela Molena, Joel E. Tepper, Thomas J. Watson, Terence Williams, Christopher Willett. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionPractical Radiation Oncology 2024; 14(1): 28 doi: 10.1016/j.prro.2023.10.001
7
Chia Ching Lee, Yu Yang Soon, Balamurugan Vellayappan, Francis Ho, Jeremy C. S. Tey. Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysisActa Oncologica 2022; 61(6): 738 doi: 10.1080/0284186X.2022.2062680
8
Stephanie G. Worrell, Karyn A. Goodman, Nasser K. Altorki, Jonathan B. Ashman, Traves D. Crabtree, Jennifer Dorth, Scott Firestone, David H. Harpole, Wayne L. Hofstetter, Theodore S. Hong, Kalie Kissoon, Geoffrey Y. Ku, Daniela Molena, Joel E. Tepper, Thomas J. Watson, Terence Williams, Christopher Willett. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionThe Annals of Thoracic Surgery 2024; 117(1): 15 doi: 10.1016/j.athoracsur.2023.09.021